Corticosteroid API Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Corticosteroid API Market Size
According to new survey, global Corticosteroid API market is projected to reach US$ 7355.8 million in 2029, increasing from US$ 5520 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2029.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-21K14628/Global_Corticosteroid_API_Market_Research_Report_2023

Corticosteroid API Market
Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma. Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Corticosteroid API market research.
Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Corticosteroid API market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-21K14628/Global_Corticosteroid_API_Market_Research_Report_2023

Segment by Type
• Cortisone
• Prednisone
• Prednisolone
• Methylprednisolone
• Dexamethasone
• Betamethasone
• Hydrocortisone
• Others

Segment by Application
• Anti-inflammatory
• Immunosuppressive
• Vasoconstrictive

By Company
Pfizer, Novartis, Aspen, Euroapi, Sanofi, Avik Pharmaceutical Limited, Symbiotec, Cipla, Abbott Laboratories, Tianjin Tianyao Pharmaceuticals Co., Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd, Shandong Xinhua Pharmaceutical Company Limited, Yangzi River Pharmaceutical Group

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-13E8579/global-corticosteroids-api

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.